EQIX vs PRAX · P/E 79, rev $5.07B vs $7.38B cap
Equinix Inc (EQIX) versus Praxis Precision Medicines Inc (PRAX) — a side-by-side from cached financials, not a winner call.
Equinix Inc (EQIX) is a reit - specialty company listed on US.
Praxis Precision Medicines Inc (PRAX) is a biotechnology company listed on US.
Latest reported EQIX revenue for 2026-06-30 was $5.07B. Net income was $894.0M. EQIX currently screens at market cap $74.23B and trailing P/E 79.4.
Latest reported PRAX revenue for 2025-09-30 was $0. Net income was -$73.9M. PRAX currently screens at market cap $7.38B.
EQIX currently screens at market cap $74.23B and trailing P/E 79.4. PRAX currently screens at market cap $7.38B.
Not investment advice. Open the EQIX and PRAX stock pages for the full models.
Not investment advice.